Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 524372 | NSE Symbol : ORCHPHARMA | ISIN : INE191A01027 | Industry : Pharmaceuticals |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
05-Nov-2024	11-Nov-2024	Quarterly Results	Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2024 inter alia to consider and approve the Unaudited Limited Reviewed Financial Results (Standalone and Consolidated) of the Company for quarter II and half year ended on September 30 2024 of Financial Year 2024-25. Outcome of Board Meeting held on November 11, 2024 (As Per BSE Announcement Dated on: 11/11/2024)
06-Aug-2024	12-Aug-2024	Quarterly Results	Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2024 inter alia to consider and approve Unaudited Limited Reviewed Financial Results (Standalone & Consolidated) of the Company for the Quarter-1 of financial year 2024-25 ended on June 30 2024 Financial Results for the quarter ended June 2024 (As per BSE Announcement dated on 12/08/2024)
17-Jul-2024	19-Jul-2024	AGM	Outcome of Board Meeting w.r.t the Re-appointment of Directors and other matters as disclosed in the letter. Considered and approved the Board Report and annexures thereto for the F.Y.2023-24 and Notice of the AGM to be held on August 21, 2024. (As Per BSE Announcement dated on 19.07.2024)
16-May-2024	23-May-2024	Accounts	Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2024 inter alia to consider and approve Audited Standalone & Consolidated Financial Results of the Company for the quarter and financial year ended on March 31 2024. Statement on Nil Deviation or Variation for proceeds of Qualified Institutions Placement for Quarter ended March 31, 2024 Audited Financial Results along with Auditor''s Report for Financial Year ended on March 31, 2024 outcome of the Board Meeting held on May 23, 2024 (As Per BSE Announcement dated on 23.05.2024)
02-Feb-2024	08-Feb-2024	Quarterly Results	Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2024 inter alia to consider and approve Un-Audited Standalone & Consolidated Financial Results of the Company for the quarter ended on December 31 2023 of the Financial Year 2023-24. Financial Results for the Quarter ended on December 31, 2023 Outcome of Board Meeting held on February 08, 2024 (As per BSE Announcement Dated on 08/02/2024)
06-Dec-2023	06-Dec-2023	Scheme of Amalgamation	Announcement under Regulation 30 of SEBI (LODR) Regulation, 2015 - Meeting Updates
28-Oct-2023	04-Nov-2023	Quarterly Results	Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2023 inter alia to consider and approve Approval of Unaudited Standalone and Consolidated Financial Results for quarter and half year ended September 30 2023 Approval of Unaudited (Standalone & Consolidated) Financial Results for the period ended September 30, 2023 (As per BSE Announcement Dated on 04/11/2023)
04-Aug-2023	10-Aug-2023	Quarterly Results	Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2023 inter alia to consider and approve Orchid Pharma Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2023 inter alia to consider and approve Un-Audited Financial Result (Standalone and Consolidated) for the quarter ended June 30 2023. Outcome of Board Meeting - Approval of Unaudited (Standalone & Consolidated) Financial Results for the quarter ended June 30. 2023 (As per BSE Announcement Dated on 10/08/2023)
27-Jun-2023	27-Jun-2023	Qualified Institutions Placements	Outcome of the Board Meeting held on June 27, 2023 Disclosure under Regulation 30 of SEBI LODR - Allotment of Equity Shares
22-Jun-2023	22-Jun-2023	Others	Outcome of the Board Meeting
03-May-2023	10-May-2023	Accounts	Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2023 inter alia to consider and approve To consider and approve Audited Financial Results (Standalone & Conso) for period ended March 31 2023 Board Meeting outcome - Audited Financial Results for period ended March 31, 2023 (As Per BSE Announcement dated on 10.05.2023)
03-Feb-2023	09-Feb-2023	Quarterly Results	Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2023 inter alia to consider and approve To approve Financial Result (Standalone and Consolidated) for the quarter ended December 31 2022 Approved Un-Audited Financial Results (Standalone & Consolidated) for quarter ended December 31, 2022. (As Per BSE Announcement Dated on 09/02/2023)
28-Nov-2022	01-Dec-2022	Raising funds through Debt Instr.	Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/12/2022 inter alia to consider and approve Board Meeting Intimation under Regulation 29 of SEBI Listing Obligations and Disclosure Requirements) Regulations 2015 Board Meeting Outcome - Announcement under Reg. 30, SEBI LODR 2015. (As per BSE Announcement Dated on 01/12/2022)
07-Nov-2022	14-Nov-2022	Quarterly Results	Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2022 inter alia to consider and approve Approval of Standalone and Consolidated Unaudited Financial Result for the quarter and half year ended September 30 2022. Approval of the Un-Audited Financial results of the Company for quarter and half year ended Sept. 30, 2022. (As Per BSE Announcement Dated on 14.11.2022)
01-Aug-2022	10-Aug-2022	Quarterly Results	Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2022 inter alia to consider and approve Un-Audited Standalone & Consolidated Financial Results of the Company for the Quarter ended 30th June 2022. We refer to our communication dated August 01, 2022 submitted to your good office pertaining to the Board Meeting to be held on August 10, 2022. Further, in accordance with Regulation 33 of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015, we would like to inform that the Board of Directors at their Meeting held today i.e., August 10, 2022 have inter-alia considered, approved and taken on record the Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter Ended June 30, 2022 (Q1 of Financial year 2022-23) along with the Limited Review Report (s) of the Statutory Auditors on the same. A copy of the Unaudited Financial Results (Standalone and consolidated) along with the Limited Review Report (s) issued by the Statutory Auditors is enclosed. (As Per BSE Announcement dated on 10.08.2022)

1 2

LOGIN HERE

Orchid Pharma Ltd

Board Meeting